Skip to main content
Signal8

Springer Graig

SEC insider (Form 3/4/5 filer). CIK 0001805261. Director at Hoth Therapeutics, Inc. (HOTH). 1 reported Form 4/5 transaction since Sep 2024; latest on Jan 14, 2025. Located in NEW YORK, NY.

Companies Springer Graig has filed insider reports for

  • Hoth Therapeutics, Inc. (HOTH): Director
Springer Graig profile photo

Springer Graig

CIK: 0001805261

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Hoth Therapeutics, Inc. logo
HOTH

Hoth Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Hoth Therapeutics, Inc. logo
    HOTH

    Hoth Therapeutics, Inc.

    Jan 14, 2025
    Award

    Options

    Indirect
    70K shares-

1-1 of 1